1. Exocarpic acid inhibits mycolic acid biosynthesis in Mycobacterium tuberculosis.
- Author
-
Koch M, Bugni TS, Sondossi M, Ireland CM, and Barrows LR
- Subjects
- Antitubercular Agents chemistry, Antitubercular Agents isolation & purification, Diynes chemistry, Diynes isolation & purification, Fatty Acids, Unsaturated chemistry, Fatty Acids, Unsaturated isolation & purification, Microbial Sensitivity Tests, Mycobacterium tuberculosis metabolism, Santalaceae chemistry, Antitubercular Agents pharmacology, Diynes pharmacology, Fatty Acids, Unsaturated pharmacology, Mycobacterium tuberculosis drug effects, Mycolic Acids metabolism
- Abstract
Exocarpic acid (13 E-octadecene-9,11-diynoic acid) from Exocarpos latifolius R.Br. (Santalaceae) was previously shown to have specific antimycobacterial activity. Microarray data suggested inhibition of fatty acid metabolism as a potential mode of action. Experiments designed to elucidate the mechanism of action showed that exocarpic acid was effective at inhibition of mycolic acid biosynthesis and did not act by dissipating the proton gradient in treated M. tuberculosis. Amide derivatives of exocarpic acid displayed similar properties to exocarpic acid, while other polyacetylenic fatty acids varied in their effects on mycolic acid biosynthesis., (© Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2010
- Full Text
- View/download PDF